Related Experiment Video
Updated: Jul 6, 2026

09:57
Measuring Naturally Acquired Phagocytosis-Inducing Antibodies to Plasmodium falciparum Parasites by a Flow Cytometry-Based Assay
Published on: August 6, 2020
Plasmodium falciparum malaria vaccines in development.
Johan Vekemans1, W Ripley Ballou
1GlaxoSmithKline Biologicals, Emerging Diseases, Global Clinical Research and Development Vaccines, Rixensart, Belgium. johan.vekemans@gskbio.com
Expert Review of Vaccines
|March 8, 2008
Summary
Developing a malaria vaccine is crucial for global health. This review covers current vaccine candidates and highlights scientific and logistical challenges for Plasmodium falciparum malaria prevention.
Area of Science:
- Immunology
- Vaccinology
- Global Health
Background:
- Malaria remains a significant global health burden, necessitating effective prevention strategies.
- A successful malaria vaccine represents a major breakthrough for controlling the disease.
- Diverse vaccine candidates are in development, targeting the complex Plasmodium falciparum lifecycle.
Purpose of the Study:
- To review the developmental status of malaria vaccine candidates in human clinical trials.
- To discuss selected preclinical-stage malaria vaccine candidates.
- To identify key challenges in malaria vaccine development.
Main Methods:
- Comprehensive literature review of malaria vaccine candidates.
- Analysis of clinical trial data for Plasmodium falciparum vaccines.
- Assessment of preclinical vaccine development pipelines.
Main Results:
- Multiple malaria vaccine candidates are in various stages of clinical testing.
- Some candidates show promise, while others have not met expectations.
- Significant scientific and non-scientific hurdles impede progress.
Conclusions:
- Malaria vaccine development requires scientific innovation and robust infrastructure.
- Collaboration between academia, industry, and funding bodies is essential.
- Sustained political commitment is vital for successful implementation.
Related Concept Videos
Malaria
Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...
Symbiosis
Symbiotic relationships are long-term, close interactions between individuals of different species that affect the distribution and abundance of those species. When a relationship is beneficial to both species, this is called mutualism. When the relationship is beneficial to one species but neither beneficial nor harmful to the other species, this is called commensalism. When one organism is harmed to benefit another, the relationship is known as parasitism. These types of relationships often...
Diversity of Protists II
Alveolates are a group of organisms recognized by the presence of alveoli, which are cytoplasmic sacs located beneath the cell membrane. While their function remains uncertain, alveoli may help regulate water balance by controlling how much water enters and leaves the cell. In dinoflagellates, these structures may serve as armor plates. There are three major types of alveolates: ciliates, which move using cilia; dinoflagellates, which use flagella for movement; and apicomplexans, which are...
Poliomyelitis
Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
Yellow Fever
Yellow fever is a viral hemorrhagic disease caused by the yellow fever virus (YFV), a member of the Flaviviridae family. It is transmitted primarily by Aedes and Haemagogus mosquitoes in tropical and subtropical regions of Africa and South America. After transmission through a mosquito bite, the virus initially replicates in skin-resident immune cells such as dendritic cells and macrophages. These cells then migrate to the lymph nodes, where viral replication increases, eventually leading to...
Vaccines
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...

